Biogen (Nasdaq: BIIB) said its Board of Directors has authorized management to evaluate whether third parties would have an interest ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE